Effects of centrally administered anxiolytic compounds in animal models of anxiety.
about
Vasopressin: behavioral roles of an "original" neuropeptideShort and long term measures of anxiety exhibit opposite resultsSocial isolation modifies nicotine's effects in animal tests of anxietyPharmacological alterations of anxious behaviour in mice depending on both strain and the behavioural situationPotential contribution of oxidative stress and inflammation to anxiety and hypertensionSex differences in anxiety, sensorimotor gating and expression of the alpha4 subunit of the GABAA receptor in the amygdala after progesterone withdrawal.Anxiolytic-like effects observed in rats exposed to the elevated zero-maze following treatment with 5-HT2/5-HT3/5-HT4 ligandsPresynaptic facilitation of glutamate release in the basolateral amygdala: a mechanism for the anxiogenic and seizurogenic function of GluK1 receptors.Cholecystokinin knock-down in the basolateral amygdala has anxiolytic and antidepressant-like effects in miceEffects of acidic-astressin and ovine-CRF microinfusions into the ventral hippocampus on defensive behaviors in rats.Genetic variation in cortico-amygdala serotonin function and risk for stress-related diseaseAmygdala-specific reduction of alpha1-GABAA receptors disrupts the anticonvulsant, locomotor, and sedative, but not anxiolytic, effects of benzodiazepines in mice.Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviourNeurobiological mechanisms contributing to alcohol-stress-anxiety interactions.Behavioral Effects of Systemic, Infralimbic and Prelimbic Injections of a Serotonin 5-HT2A Antagonist in Carioca High- and Low-Conditioned Freezing Rats.Role of the PLC-related, catalytically inactive protein p130 in GABA(A) receptor function.Therapeutic potential of serotonin antagonists in depressive disorders.Combined exposure to nicotine and ethanol in adolescent mice differentially affects anxiety levels during exposure, short-term, and long-term withdrawal.Cellular correlates of anxiety in CA1 hippocampal pyramidal cells of 5-HT1A receptor knockout mice.Measures of anxiety, amygdala volumes, and hippocampal scopolamine phMRI response in elderly female rhesus macaques.A pharmacological analysis of an associative learning task: 5-HT(1) to 5-HT(7) receptor subtypes function on a pavlovian/instrumental autoshaped memory.Behavioral characterization of mice lacking Trek channels.β1-adrenoceptor activation is required for ethanol enhancement of lateral paracapsular GABAergic synapses in the rat basolateral amygdalaSerotonergic innervation and serotonin receptor expression of NPY-producing neurons in the rat lateral and basolateral amygdaloid nuclei.Localized injections of midazolam into the amygdala and hippocampus induce differential changes in anxiolytic-like motor activity in miceChemogenetic and Optogenetic Activation of Gαs Signaling in the Basolateral Amygdala Induces Acute and Social Anxiety-Like StatesDynamic gene and protein expression patterns of the autism-associated met receptor tyrosine kinase in the developing mouse forebrainMicroinjection of naltrexone into the central, but not the basolateral, amygdala blocks the anxiolytic effects of diazepam in the plus mazeEffect of β3 adrenoceptor activation in the basolateral amygdala on ethanol seeking behaviors.Contextual conditioning in rats as an animal model for generalized anxiety disorder.Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety.Modulation of hippocampal neuronal activity by So-ochim-tang-gamibang in mice subjected to chronic restraint stress.Novelty and anxiolytic drugs dissociate two components of hippocampal theta in behaving rats.The role of amygdalar mu-opioid receptors in anxiety-related responses in two rat models.Lateral paracapsular GABAergic synapses in the basolateral amygdala contribute to the anxiolytic effects of beta 3 adrenoceptor activation.Inhibition of the NMDA receptor/Nitric Oxide pathway in the dorsolateral periaqueductal gray causes anxiolytic-like effects in rats submitted to the Vogel conflict test.New replicable anxiety-related measures of wall vs center behavior of mice in the open field.Effects of transgenic overproduction of CRH on anxiety-like behaviour.Ethanol inhibition of kainate receptor-mediated excitatory neurotransmission in the rat basolateral nucleus of the amygdala.GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice.
P2860
Q24656284-FF5352C1-6C6E-44AE-881F-5226913D1D76Q27342198-C25B9FD5-ED24-410E-BBC5-2375E6F1F948Q28361172-8F6B4817-7555-479D-89DA-531846D982E5Q28471826-33A89982-A929-4428-B94F-A4C61C67F193Q28576099-46AAE785-358D-41FE-A18F-7C9AF2613DD6Q28579679-4F82F101-11BB-4B7A-94FF-228A92E7807DQ30359106-93D20CDF-2EEA-4FDE-BC50-AE32BC59645DQ30448913-37B51554-F6B5-4101-96EE-1C126F8D599CQ30450150-51D48FB6-43F9-4F87-9A35-75990CCBE928Q30481245-2ABCDB07-3618-4FF0-9726-7FC1B1F622D6Q30487278-15DDC5B2-0BCB-4839-9AC5-E93F1736AFDAQ30495530-233C0F98-7915-4A19-BFF0-023B0699DE51Q30522548-54DCB7A7-6EC2-4380-B457-5A46E486DFDAQ33622357-EB32EA5B-0E94-4F21-99CB-D5EA60DA394AQ33881804-E1886BFA-72BE-4937-BE42-0D7186C8E421Q34085948-7FE1DCE2-9EEE-4217-83D1-15AB0C572048Q34581475-13E5BA54-5C0F-4494-95D5-B344AA69E0B2Q34623008-2D063EB0-B3F8-40DC-8C93-FD9FCA26A53CQ35032878-C3D29F98-DE88-4A7C-9ED0-CC4B75B7C80CQ35376700-5132FDA6-05A5-4CFF-A1FD-ACE97ECDD1D3Q35558964-C2A46A59-0B76-4F34-BC62-3659929E55DEQ36213793-7DC4097E-1392-4823-AC59-80DE3AFC90CBQ36335513-A34072DD-A3C8-4AEF-879B-D27048B0BC53Q36632083-9CA7DBFD-D871-4799-8A9F-AD95697DFE37Q36852081-A4214A3F-9487-42B5-8F20-0F376773005DQ37006297-EA1B4939-88D3-4AD2-9E53-C15B1DCAC3FEQ37110137-6006B2F0-680C-4231-BD9C-7365853760ADQ37184078-370D1BB9-EAFA-417E-886F-41748202AB10Q37424549-43310DEC-94A0-4549-8BEB-2886EB9CA05BQ37837718-81D162BD-0E70-4E0B-A1EA-BFEA73FAF685Q38089644-43E530E2-AD48-42AF-8AD3-0D7AE96459D5Q41468208-AEF76F79-16C1-4DE0-AC2A-0A96D9DDDE23Q41871699-ED730E6F-5838-48D4-92AD-3F445C27FFE8Q42022457-E591A6BA-AD01-43AC-B1C1-005520360A28Q42055845-1DC624FB-719B-4947-91E2-C932730EAEC3Q42154035-A401B83A-D6EC-4DC9-8497-EA2D94D09128Q42620889-775B6621-B710-440C-9B34-A56C396C3703Q42679730-4FC69DAF-D682-42F3-A205-7A5FD139F81BQ43210861-D0FAE8D4-5FC3-4305-B201-0C389CFD1C6DQ44374768-D2FA4FB0-22F4-4C0F-A4EE-0EDF538A9317
P2860
Effects of centrally administered anxiolytic compounds in animal models of anxiety.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Effects of centrally administered anxiolytic compounds in animal models of anxiety.
@ast
Effects of centrally administered anxiolytic compounds in animal models of anxiety.
@en
Effects of centrally administered anxiolytic compounds in animal models of anxiety.
@nl
type
label
Effects of centrally administered anxiolytic compounds in animal models of anxiety.
@ast
Effects of centrally administered anxiolytic compounds in animal models of anxiety.
@en
Effects of centrally administered anxiolytic compounds in animal models of anxiety.
@nl
prefLabel
Effects of centrally administered anxiolytic compounds in animal models of anxiety.
@ast
Effects of centrally administered anxiolytic compounds in animal models of anxiety.
@en
Effects of centrally administered anxiolytic compounds in animal models of anxiety.
@nl
P1476
Effects of centrally administered anxiolytic compounds in animal models of anxiety.
@en
P2093
P304
P356
10.1016/S0149-7634(98)00056-6
P577
1999-03-01T00:00:00Z